Brief: Castle Biosciences Q1 Revenue USD 83.679 Million Vs. IBES Estimate USD 79.4 Million
06/05/2026 21:05
May 06 (Reuters) - Castle Biosciences Q1 operating expenses USD 102.086 million. Q1 operating income USD -18.407 million Q1 pretax profit USD -14.413 million Q1 net income USD -14.522 million Q1 basic EPS USD -0.49
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million